# ClinicalTrials.gov record NCT00099086

> PeptideScanner retained ClinicalTrials.gov record NCT00099086 at 2026-07-30T18:49:14.746Z. Its registry update date was 2024-01-31, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct00099086-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2024-01-31
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00099086-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00099086-leuprolide-v1.json
- Content SHA-256: `85b3c30abd965c1cba80a89e5d4281eb2bee0d6eb15b7b8443bbfc19361453a8`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00099086 ([`ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84`](#source-ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00099086 at 2026-07-30T18:49:14.746Z. Its registry update date was 2024-01-31, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84`](#source-ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00099086 at 2026-07-30T18:49:14.746Z. Its registry update date was 2024-01-31, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84`](#source-ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84`](#source-ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84))

## Sources

<a id="source-ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84"></a>
- **ClinicalTrials.gov record NCT00099086 · retained source version 2024-01-31:30d1ac4d8d84143c81ce08ba0574b5b0711236d45ab23c168fad4f9fbce4a565** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00099086) (`ctg-observation-nct00099086-2024-01-31-30d1ac4d8d84`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00099086." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00099086-leuprolide-v1.json SHA-256: 85b3c30abd965c1cba80a89e5d4281eb2bee0d6eb15b7b8443bbfc19361453a8.